Clinical Trial Update: A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a Phase 1/2 pilot trial evaluating EW02 for safety and its ability to reduce chemotherapy-induced neutropenia in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• EW02

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Breast Cancer, Chemotherapy | Phase 1, Phase 2 | Status: UNKNOWN